Stock listing

26CA Stock Price, News, Filings & Events — Immunitybio, Inc.

Selected listing: 26CA · HAM · EUR · DE

This page tracks Immunitybio, Inc.'s 26CA:HAM listing on HAM in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 26CA:HAM. 26CA:HAM is the stock-level entry point for investors researching Immunitybio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Immunitybio, Inc. (Ticker: IBRX) is a public company based in the United States, with a market capitalization of approximately $8.04 billion. The company focuses on developing innovative immunotherapy solutions to address various diseases. Its commitment to advancing healthcare through cutting-edge research positions it as a key player in the biotechnology sector.